Progress of research on molecular targeted therapies for colorectal cancer
Colorectal cancer (CRC) is one of the most common malignancies, accounting for approximately 10% of global cancer incidence and mortality. Approximately 20% of patients with CRC present metastatic disease (mCRC) at the time of diagnosis. Moreover, up to 50% of patients with localized disease eventua...
Saved in:
Main Authors: | Shilin Huang (Author), Jiazhou Ye (Author), Xing Gao (Author), Xi Huang (Author), Julu Huang (Author), Lu Lu (Author), Cheng Lu (Author), Yongqiang Li (Author), Min Luo (Author), Mingzhi Xie (Author), Yan Lin (Author), Rong Liang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Homologous Recombination Pathway Alternation Predicts Prognosis of Colorectal Cancer With Chemotherapy
by: Yan Lin, et al.
Published: (2022) -
A Mitochondria-Targeted Heptamethine Indocyanine Small Molecular Chelator for Attenuating Uranium Nephrotoxicity
by: Zaizhi Du, et al.
Published: (2024) -
Molecularly targeted drugs for metastatic colorectal cancer
by: Cheng YD, et al.
Published: (2013) -
Molecular targeted therapy for metastatic colorectal cancer: current and evolving approaches
by: Furong Li, et al.
Published: (2023) -
Research Progress on PARP14 as a Drug Target
by: Wei Qin, et al.
Published: (2019)